Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,000
+850 (4.68%)
Aug 8, 2025, 3:30 PM KST
4.68%
Market Cap249.23B
Revenue (ttm)91.93B
Net Income (ttm)-8.75B
Shares Out13.73M
EPS (ttm)-631.75
PE Ration/a
Forward PEn/a
Dividend500.00 (2.76%)
Ex-Dividend DateDec 27, 2024
Volume21,940
Average Volume26,060
Open18,190
Previous Close18,150
Day's Range18,190 - 19,240
52-Week Range9,720 - 23,850
Beta1.60
RSI44.47
Earnings DateAug 14, 2025

About Verve Therapeutics

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 354
Stock Exchange KOSDAQ
Ticker Symbol 036220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.